https://www.selleckchem.com/pr....oducts/cilofexor-gs-
IgG antibodies reacting to the corresponding CTX-M enzyme was seen in 28 % (13/47) of patients suffering from EPE-bacteremia, while antibodies were detected in only 9.5 % (4/42) of patients with 3GCSE (p = 0.03). Patients with EPE had a statistically significantly higher median Charlson comorbidity index and prevalence of renal disease (p = 0.01), compared to the 3GCSE control group. This study implies that EPE bacteremia can trigger production of IgG antibodies targeting ESBL. Further investigations are required to determine
כמו
תגובה
לַחֲלוֹק
